11 episodes

'A Chat with Anat' is a series for ophthalmologists who are interested in improving delivery of care and improved outcomes for patients living with neovascular age-related macular degeneration (nAMD). I’m Professor Anat Loewenstein, Chair of the Department of Ophthalmology at Tel Aviv Sourasky Medical Centre in Israel, and Professor of Ophthalmology and Vice Dean at Tel Aviv University. For each episode, I will be joined by internationally renowned colleagues to discuss key topics on patient-focused care. This podcast series is sponsored and organised by Bayer and produced by ApotheCom. This is not intended for UK audiences.

A Chat with Anat ApotheCom

    • Science

'A Chat with Anat' is a series for ophthalmologists who are interested in improving delivery of care and improved outcomes for patients living with neovascular age-related macular degeneration (nAMD). I’m Professor Anat Loewenstein, Chair of the Department of Ophthalmology at Tel Aviv Sourasky Medical Centre in Israel, and Professor of Ophthalmology and Vice Dean at Tel Aviv University. For each episode, I will be joined by internationally renowned colleagues to discuss key topics on patient-focused care. This podcast series is sponsored and organised by Bayer and produced by ApotheCom. This is not intended for UK audiences.

    Pachychoroid: Current concepts on clinical features and pathogenesis

    Pachychoroid: Current concepts on clinical features and pathogenesis

    In this episode, Vision Academy members Professor Annabelle Okada, Professor of Ophthalmology and Director of the Ocular Inflammation Service and the Macular Disease Service at the Kyorin University School of Medicine in Japan, and Professor Ian Pearce, Consultant Ophthalmologist and Vitreoretinal Surgeon at the Royal Liverpool University Hospital in the UK, discuss the pachychoroid spectrum.Using practical examples from their own clinics, they explore how accurate diagnosis, monitoring, prog...

    • 28 min
    Are we entering a new era for patients and clinicians?

    Are we entering a new era for patients and clinicians?

    My guest for this special episode recorded live at the 15th Annual Congress on Controversies in Ophthalmology (COPHy) is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at University of Manchester, United Kingdom. In this episode, Tariq and I discuss whether the introduction of next generation therapies for the clinical management of retinal diseases will open the door to a new era for patients and clinicians.We also consider how learnings from the Barometer ...

    • 13 min
    Characterization of macular neovascularization subtypes in nAMD to optimize treatment outcomes

    Characterization of macular neovascularization subtypes in nAMD to optimize treatment outcomes

    My guest for this episode is Professor Nicole Eter, Professor of Ophthalmology and Chair of the Department of Ophthalmology at the University of Münster, Germany. In this episode, Nicole and I chat about the different macular neovascularization (MNV) subtypes, discussing the diagnostic tools used to classify MNV subtypes, their defining characteristics and variants, and the impact of these on our patients. Our conversation highlights why it’s important to tailor treatment to MNV subtype for o...

    • 20 min
    Optimal anti-VEGF therapy regimen

    Optimal anti-VEGF therapy regimen

    In this episode, Professor Paul Mitchell, Professor of Ophthalmology at the University of Sydney in Australia, and Dr Andrew Chang, Principal Retinal Specialist at the Sydney Retina Clinic and Day Surgery in Australia, share their thoughts on the optimal anti-VEGF therapy regimens to treat retinal vascular diseases, including nAMD and DME. They discuss how the best regimen should be effective in maintaining vision, proactive, individualized to the patient’s needs, and convenient for the patie...

    • 28 min
    Reducing the burden of bilateral injections

    Reducing the burden of bilateral injections

    We are delighted to announce that we are expanding A Chat with Anat! We will be partnering with the Vision Academy, a group of retinal experts who collaborate to provide guidance to the retinal community. I will be joined by internationally renowned Vision Academy experts to discuss practice-focused topics covering clinical challenges in ophthalmology and controversies in care. In this episode of A Chat with Anat, Professor Paul Mitchell, Professor of Ophthalmology at the University of S...

    • 20 min
    Navigating anxiety and depression in patients with nAMD

    Navigating anxiety and depression in patients with nAMD

    My guest for this episode is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at the University of Manchester and a Consultant Ophthalmologist specializing in the management of retinal disease.In this episode, Professor Aslam and I chat about how important it is to consider anxiety and depression when managing our patients with neovascular age-related macular degeneration. Our conversation covers the quick yet effective measures that Professor Aslam has implemented...

    • 16 min

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Radiolab
WNYC Studios
Ologies with Alie Ward
Alie Ward
StarTalk Radio
Neil deGrasse Tyson
Something You Should Know
Mike Carruthers | OmniCast Media
Short Wave
NPR